CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
59.75
0.93 (1.58%)
At close: Aug 15, 2025, 10:56 AM
CRISPR Therapeutics Fail-to-Deliver
Total FTD Shares
9.3K
Below Average
FTD / Avg. Volume
0.28%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
CRISPR Therapeutics AG has
9,303
shares failed to deliver, representing 0.28%
of the average daily volume of
3,300,427.6
shares. Over the past year, the monthly average FTD is
22,625
shares, with the current level 59% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 56.42 | 9.3K | -98.87% |
Jun 30, 2025 | 48.64 | 823.53K | +281930.14% |
May 30, 2025 | 36.29 | 292 | -99.25% |
Apr 30, 2025 | 38.67 | 38.97K | +59.84% |
Mar 31, 2025 | 34.03 | 24.38K | +78535.48% |
Feb 27, 2025 | 43.62 | 31 | -98.63% |
Jan 31, 2025 | 41.59 | 2.26K | -50.12% |
Dec 27, 2024 | 40.02 | 4.53K | +408.65% |
Nov 29, 2024 | 51.17 | 890 | -97.86% |
Oct 31, 2024 | 46.39 | 41.6K | +18471.43% |
Sep 30, 2024 | 46.98 | 224 | -99.47% |
Aug 30, 2024 | 47.72 | 42.2K | +769.68% |
Jul 30, 2024 | 56.41 | 4.85K | +2641.24% |
Jun 28, 2024 | 54.01 | 177 | +268.75% |
May 31, 2024 | 53.74 | 48 | -99.93% |
Apr 25, 2024 | 53.73 | 70.03K | +2650.51% |
Mar 27, 2024 | 70.16 | 2.55K | +8112.90% |
Feb 29, 2024 | 84.22 | 31 | -98.75% |
Jan 30, 2024 | 64.48 | 2.48K | -66.38% |
Dec 28, 2023 | 64.3 | 7.38K | +746.96% |
Nov 29, 2023 | 69.09 | 871 | -57.64% |
Oct 27, 2023 | 38.74 | 2.06K | -96.42% |
Sep 29, 2023 | 45.39 | 57.44K | +20636.46% |
Aug 11, 2023 | 49.65 | 277 | -22.84% |
Jul 31, 2023 | 57.33 | 359 | -78.45% |
Jun 28, 2023 | 57.16 | 1.67K | +880.00% |
May 31, 2023 | 64.04 | 170 | +91.01% |
Apr 28, 2023 | 48.94 | 89 | -98.29% |
Mar 31, 2023 | 45.23 | 5.21K | -90.09% |
Feb 28, 2023 | 49.32 | 52.55K | +20110.38% |
Jan 30, 2023 | 49.96 | 260 | n/a |